Φορτώνει......
Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
INTRODUCTION: Childhood chronic myeloid leukemia (CML) accounts for less than 3% of all childhood leukemias, hence, data on imatinib (IM) in adult CML patients has been largely extrapolated to children. We have analyzed our data to add to the existing literature. AIMS: Primary objective is to assess...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | South Asian J Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Medknow Publications & Media Pvt Ltd
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236696/ https://ncbi.nlm.nih.gov/pubmed/25422804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.142961 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|